Postmenopausal hormone therapy and cardiovascular risk
VandeKieft, G.
Journal of Family Practice 43(5): 437-438
1996
ISSN/ISBN: 0094-3509 PMID: 8917138 Document Number: 455480
Document emailed within 1 workday
Related Documents
Zhang, Y. 2002: Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases Zhonghua Fu Chan Ke Za Zhi 37(6): 321-323Chen, F.P.; Lee, N.; Soong, Y.K.; Huang, K.E. 2001: Short- and long-term effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women Chang Gung Medical Journal 24(7): 431-439
Chae, C.U.; Ridker, P.M.; Manson, J.E. 1997: Postmenopausal hormone replacement therapy and cardiovascular disease Thrombosis and Haemostasis 78(1): 770-780
Middeldorp, S.; Büller, H.R.; Vandenbroucke, J.P.; Helmerhorst, F.M.; Rosendaal, F.R. 2002: Adverse cardiovascular effects of postmenopausal hormone replacement therapy Nederlands Tijdschrift Voor Geneeskunde 146(45): 2123-2127
Shah, S.; Rhodes, L. 1997: Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Search for studies was limited Bmj 315(7109): 676-7; Author Reply 678-9
Lapidus, L.; Lindstedt, G.; Lundberg, P.A.; Bengtsson, C.; Gredmark, T. 1986: Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women Clinical Chemistry 32(1 Part 1): 146-152
Chen, F.-P. 2009: Postmenopausal hormone therapy and risk of breast cancer Chang Gung Medical Journal 32(2): 140-147
Lacut, K.; Oger, E. 2005: Hormone therapy and risk for venous thromboembolism in postmenopausal women La Revue du Praticien 55(4): 389-392
Seagroatt, V. 1997: Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Paper's main conclusion is no longer justified when data from all trials are considered Bmj 315(7109): 677; Author Reply 678-9
Simon, T.; Jaillon, P. 2001: Hormone replacement therapy and cardiovascular risk in menopausal women Archives des Maladies du Coeur et des Vaisseaux 94(2): 132-138
Kuttenn, F.; Gerson, M.; de Lignères, B. 2002: Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study Presse Medicale 31(10): 468-475
Kessler, C.M.; Legault, C. 1995: Effect of hormone replacement therapy on the activities of factor VII and protein C in postmenopausal women women The postmenopausal estrogen/progestin intervention trial Blood 86(10 Suppl 1): 200A
Ciammella, M.; Guareschi, B.; Pes, S.; Cocucci, C.; Nencioni, T. 1993: Substitution estrogen therapy in the prevention of postmenopausal osteoporosis and cardiovascular diseases. Results of long-term therapy Minerva Ginecologica 45(1-2): 53-55
Mascitelli, L.; Pezzetta, F. 2003: Postmenopausal hormone replacement therapy Italian heart journal: official journal of the Italian Federation of Cardiology 4(6): 423; author reply 423-5
Magee, S.R.; Taylor, J.S. 2006: Hormone therapy in postmenopausal and perimenopausal women American Family Physician 74(9): 1501-1503
MacLean, D.B.; Bostom, A. 1992: Postmenopausal estrogen therapy and cardiovascular disease New England Journal of Medicine 326(10): 707-708
Prior, J.C. 1992: Postmenopausal estrogen therapy and cardiovascular disease New England Journal of Medicine 326(10): 705
Goodman, H.M.; Kredentser, D.; Deligdisch, L. 1989: Postmenopausal endometriosis associated with hormone replacement therapy. A case report Journal of Reproductive Medicine 34(3): 231-233
Keating, N.L.; Cleary, P.D.; Rossi, A.S.; Zaslavsky, A.M.; Ayanian, J.Z. 1999: Use of hormone replacement therapy by postmenopausal women in the United States Annals of Internal Medicine 130(7): 545-553
Fylstra, D.L. 2002: Postmenopausal hormone replacement therapy: does the progestin make a difference? Journal of the South Carolina Medical Association 98(1): 12-19